IRIS
1.5 Abstract in rivista
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 19.518
NA - Nord America 11.211
EU - Europa 4.285
SA - Sud America 1.386
AF - Africa 211
Continente sconosciuto - Info sul continente non disponibili 114
OC - Oceania 94
Totale 36.819
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 14.006
US - Stati Uniti d'America 10.715
CN - Cina 2.297
IT - Italia 2.145
HK - Hong Kong 1.310
BR - Brasile 982
GB - Regno Unito 653
VN - Vietnam 553
FR - Francia 496
BD - Bangladesh 331
IN - India 308
DE - Germania 268
CA - Canada 255
AR - Argentina 145
NL - Olanda 116
ID - Indonesia 108
TR - Turchia 102
MX - Messico 95
CO - Colombia 76
EC - Ecuador 76
RU - Federazione Russa 76
AU - Australia 66
CZ - Repubblica Ceca 57
EE - Estonia 57
FI - Finlandia 57
JP - Giappone 54
PK - Pakistan 53
UA - Ucraina 53
ES - Italia 47
PL - Polonia 45
SA - Arabia Saudita 45
ZA - Sudafrica 43
MY - Malesia 41
PH - Filippine 40
IQ - Iraq 39
IL - Israele 33
EG - Egitto 32
CL - Cile 31
JM - Giamaica 29
VE - Venezuela 27
PY - Paraguay 25
MD - Moldavia 23
NZ - Nuova Zelanda 22
SE - Svezia 22
AE - Emirati Arabi Uniti 21
IE - Irlanda 21
TW - Taiwan 20
AT - Austria 19
SC - Seychelles 19
CR - Costa Rica 17
NP - Nepal 17
ET - Etiopia 16
MA - Marocco 16
TN - Tunisia 16
HN - Honduras 15
DO - Repubblica Dominicana 14
TH - Thailandia 14
CH - Svizzera 13
KZ - Kazakistan 13
AZ - Azerbaigian 12
GT - Guatemala 12
LT - Lituania 12
UZ - Uzbekistan 12
BE - Belgio 11
IR - Iran 11
UY - Uruguay 11
KE - Kenya 10
KW - Kuwait 10
NI - Nicaragua 10
TT - Trinidad e Tobago 10
DK - Danimarca 9
HU - Ungheria 9
KR - Corea 9
OM - Oman 9
PR - Porto Rico 9
PT - Portogallo 9
GH - Ghana 8
NO - Norvegia 8
RO - Romania 8
SV - El Salvador 8
AL - Albania 7
DZ - Algeria 7
NG - Nigeria 7
PE - Perù 7
GP - Guadalupe 6
RS - Serbia 6
SK - Slovacchia (Repubblica Slovacca) 6
AM - Armenia 5
BO - Bolivia 5
CW - ???statistics.table.value.countryCode.CW??? 5
GR - Grecia 5
JO - Giordania 5
KG - Kirghizistan 5
LB - Libano 5
LY - Libia 5
SI - Slovenia 5
BB - Barbados 4
BG - Bulgaria 4
BH - Bahrain 4
KH - Cambogia 4
Totale 36.619
Salva come PNG Salva come JPEG
Città #
San Jose 2.799
Ashburn 2.231
Singapore 1.772
Rome 1.427
Hong Kong 1.285
Hefei 986
Dallas 694
Council Bluffs 690
Boardman 583
Columbus 501
London 464
Beijing 452
Lauterbourg 432
Shanghai 342
Ho Chi Minh City 209
Los Angeles 200
New York 162
Santa Clara 147
Hanoi 132
San Francisco 128
Pune 114
Phoenix 107
São Paulo 95
Milan 92
West Jordan 90
Amsterdam 71
Munich 70
Toronto 67
Washington 63
Chicago 58
Seattle 50
Brooklyn 47
Naples 46
Montreal 44
Mexico City 43
Brno 41
Denver 38
Buffalo 37
Warsaw 37
Sona 36
Tokyo 36
Las Vegas 35
Turku 35
Atlanta 34
Rio de Janeiro 31
Frankfurt am Main 30
Quito 29
Chennai 25
Guayaquil 24
Haiphong 24
Riyadh 23
Brasília 22
Florence 22
Helsinki 22
Kuala Lumpur 22
Melbourne 22
Boston 21
Jakarta 21
Da Nang 20
Manchester 19
Orem 19
Bogotá 18
Canberra 18
Charlotte 18
Hanover 18
Istanbul 18
Nuremberg 18
Paris 18
Bologna 17
Buenos Aires 17
New Delhi 17
Philadelphia 17
Baghdad 16
Jeddah 16
Johannesburg 16
San José 16
Turin 16
Jacksonville 15
Kingston 15
Porto Alegre 15
Stockholm 15
Sydney 15
Thái Bình 15
Cairo 14
Curitiba 14
Dhaka 14
Hải Dương 14
Central 13
Dublin 13
Ankara 12
Belo Horizonte 12
Biên Hòa 12
Catania 12
Manila 12
Pittsburgh 12
Addis Ababa 11
Bangkok 11
Brescia 11
Campinas 11
Glasgow 11
Totale 17.991
Salva come PNG Salva come JPEG
Nome #
PLASTIC IN PLACENTA: WHAT IS IT? WHAT TO DO? 452
112P Measuring time-toxicity and prognostic impact of hospital attendance in early phase cancer trials participants 350
18F-Choline PET/CT for early detection of prostate cancer recurrence after radical prostatectomy 342
1352P Real-world second-line outcomes of NSCLC patients receiving first-line chemotherapy plus immunotherapy 331
1338P TP53 truncating and missense mutations are linked to differential response to checkpoint blockade in patients with advanced non-small cell lung cancer (NSCLC) 321
1065P Dose dependent detrimental effect of baseline pantoprazole on clinical outcomes from first-line chemo-ICI regimens in patients with advanced stage NSCLC 316
69P Dose-dependent detrimental effect of proton pump inhibitors (PPIs) on clinical outcomes from immune checkpoint inhibitors (ICI) in patients (pts) with solid tumors 268
NEW TECHNOLOGIES IN RADIOTHERAPY FOR PROSTATE CANCER: FEASIBILITY, DOSIMETRIC ASPECTS AND CLINICAL RESULTS IN PATIENTS WITH AT LEAST 5-YEAR FOLLOW-UP 259
1-year results of the subclavian access for tavi with the corevalve bioprosthesis in 132 consecutive patients 259
96P Induction chemotherapy backbone in frail patients (pts) with advanced NSCLC treated with chemotherapy plus pembrolizumab (P): A single institution retrospective audit of dose intensities from modified regimens 252
Abstract 486: MicroRNA-30 family members inhibit breast cancer invasion, osteomimicry, and bone destruction by directly targeting multiple bone metastasis-associated genes 251
A new adjunct for emergency airway management:the Laryngeal Tube, preliminary data 246
18F-CHOLINE PET/CT FOR EARLY DETECTION OF PROSTATE CANCER RECURRENCE AFTER RADICAL PROSTATECTOMY 245
Effect of hypothermia on human colonic smooth muscle contractility 243
Early opioid exposure (EOE) and impaired efficacy in patients with advanced NSCLC treated with PD-L1 inhibition: A pooled post hoc analysis of the POPLAR and OAK trials 241
METAL HOMEOSTASIS IN PATIENTS WITH PORTO-SYSTEMIC ENCEPHALOPATHY 237
A biomechanical index for the evaluation of upper arm motor control in a subject affected by polyradiculoneuropathy 236
Purse-String Closure vs Conventional Direct Closure of Wounds after Stoma Reversal: A Prospective Randomized Controlled Study 235
Disclosing 3D Shape of Ossa Genitalia in Primates 230
Diagnosis of labour: the II prospective clinical study 227
602 Frequent Epigenetic Inactivation of KEAP1 Gene in Breast Cancer 227
P3.13C.09 First-Line Treatments for Advanced Pure Large Cell Neuroendocrine Tumors (LCNEC):Insights from a Global Clinico-Genomic Study 226
QUALITY ASSURANCE FOR CLINICAL PRACTICE IN CERVICAL CANCER BRACHYTHERAPY WITH IR-192 SOURCE: IN VIVO DOSIMETRY WITH QED DIODES 225
Postoperative Serum Procalcitonin to Predict Clinically Relevant Pancreatic Fistula after Pancreatoduodenectomy 225
Gait Speed Is a Valid Indicator in the Assessment of Perioperative Risk in the Elderly Surgical Patient 222
Adipokines: The Missing Link between Alzheimer's Disease and Type 2 Diabetes? 222
3D Bioprinting of Human Skin and Squamous Cell Tumors (SCCs) as Advanced Models for Precision Medicine (BIOSQIN) 221
Chronotherapy and surgery for unresectable hepatic metastases from colorectal cancer 221
Delayed surgery after radio-chemotherapy for rectal adenocarcinoma is protective for anastomotic dehiscence: a single centre retrospective analysis 220
EP24.13: Fetomaternal hemorrhage: a new hypothesis on the importance of fetal vasoconstriction – a case report 218
BREATH PRINT ANALYSIS BY E-NOSE IS ASSOCIATED WITH ADVERSE OUTCOMES OF CIRRHOTIC PATIENTS INDEPENDENTLY FROM THE OTHER PROGNOSTIC INDICES 217
Does HE4 have a role in the recurrence of ovarian cancer? 215
AB0550 PHENOTYPE OF BIOPSY-PROVEN PATIENTS WITH PRIMARY SJÖGREN SYNDROME LACKING RO AUTOANTIBODIES: HIGH FREQUENCY OF DRYNESS SYMPTOMS WITH LOW SYSTEMIC ACTIVITY (BIG DATA SJÖGREN PROJECT) 213
Assessment of liver function by the exhaled breath-print during chronic liver disease 211
Aligned electrospun poly-l-lactide fibers for tendon regeneration: a preliminary in vitro study 211
APPLICATION OF RADIOFREQUENCY INTERSTITIAL TUMOR ABLATION(RITA) IN "NO CLAMP-NO SUTURE" LAPAROSCOPIC PARTIAL NEPHRECTOMY 210
Risultati preliminari dell’uso della risonanza magnetica nello studio dei disturbi dell’evacuazione 208
Aberrant expression of IL-22RA1 on hematopoietic cells as immunologically signature of primary sjogren’s syndrome and sjogren-associated non-hodgkin lymphomas 200
The Hendrich II model for assessing the risk of falls for hospitalized patients [Il modello Hendrich II per la valutazione del rischio di cadute per pazienti ospedalizzati] 197
AB0458 A PHASE II RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PROOF OF CONCEPT STUDY OF ORAL SELETALISIB IN PATIENTS WITH PRIMARY SJÖGREN’S SYNDROME (PSS) 197
CARBOPLATINUM IN NEOADJUVANT CHEMOTHERAPY FOR LOCALLY ADVANCED CERVICAL CANCER: A PILOT STUDY. 197
Hepatic Artery Anomaly Does Not Impact Pancreatoduodenectomy Outcomes: A Matched Pair Analysis 196
Biomimetic Polyurethane Scaffolds Guiding the In Vitro Behavior of Cardiac Stem Cells 192
534 Determinants of 5-year survival in patients with advanced NSCLC with PD-L1 ≥50% treated with first line pembrolizumab outside of clinical trials: results from the Pembro-real 5Y global registry 187
THU-390 - Hepatic expression of lysosomal acid lipase is reduced in non-alcoholic fatty liver disease and inversely associated with the degree of microvescicular steatosis, impairment of the autophagic process and NAFLD activity score 182
18F-CHOLINE PET/CT FOR EARLY DETECTION OF PROSTATE CANCER RECURRENCE AFTER RADICAL PROSTATECTOMY. 172
OS-078-YI Hepatic decompensation as an aetiology-dependent determinant of mortality in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab 161
EBUS-TBNA, EUS-FNA or EUS-B-FNA for mediastinal staging of lung cancer: A purpose of diagnostic algorithm 160
A polysaccharide foam-like scaffold obtained by crosslinking lactose-modified chitosan and oxidized hyaluronan 158
Cerebral Hemodynamics, Patent foramen ovale and White Matter Hyperintensities in patients Migraine with aura, young stroke patients and controls 155
35. Association of robot-assisted rehabilitation and non-invasive brain stimulation to improve upper limb function in chronic stroke patients 155
Abruptio placenta and TLRs 2-3-4 151
A case of synchronous hepatic and gastric malignancies: diagnostic problems and therapeutical strategies 150
42P Radiation induced pneumonitis in the era of the COVID-19 pandemic: Artificial intelligence for differential diagnosis 150
485 Impact of opioid signaling on the tumor microenvironment and clinical outcomes in patients with non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (ICIs) 147
706. DNA Vaccine Strategy Against Chronic B-Cell Lymphoma: Anti-Idiotypic CDR3 Vaccination 147
Prospective observational multicentric case-control study about 'fatigue' in patients with history of breast cancer 144
Alimentazione e gravidanza fisiologica 144
GH-resistance in different stages of chronic liver disease 143
Abstract P5-04-13: Antibody-based therapy targeting integrin a5 is an effective strategy to treat experimental breast cancer bone metastasis 140
A New Technique for Laparoscopic Stripping of Endometriomas: FloSeal Hemostatic Agent for Hemostasis of the Ovarian Wall 138
A Systematic Review of the Role of Lymphadenectomy in Pancreatic Cancer 137
A meta-synthesis of experiences of caregivers of people with COPD. 136
"NO CLAMP NO SUTURE'' LAPAROSCOPIC PARTIAL NEPHRECTOMY FOR SMALL EXOPHYTIC RENAL TUMORS 136
Biological effects of cabozantinib on bone microenvironment 136
Afatinib, an irreversible ErbB family inhibitor, demonstrates activity against HER2 mutated cervical cancer in vitro 133
Amniotic membrane transplantation associated with conjunctival peritomy in the management of Mooren's ulcer. 132
ASSESSING PRO-INFLAMMATORY PROPERTIES OF H-FERRITIN BY EX VIVO AND IN VITRO OBSERVATIONS 132
35 DNA DOUBLE STRANDS BREAK REPAIR GENES EXPRESSION ANALYSIS REVEAL RAD51 AS A NEW POTENTIAL BIOMARKER IN BREAST CANCER. 132
Clinical outcomes and post-progression retreatment in patients with metastatic NSCLC who complete two years of treatment with immune checkpoint blockade 131
A randomized phase II study assessing an optimized schedule of oregovomab (0) anti-CA1 25 vaccination with carboplatin paclitaxel (CP) relative to CP alone in front-line treatment of optimally cytoreduced stage III/IV ovarian cancer (EOC) 131
METAL METABOLISM IMPAIRMENT IN PATIENTS WITH HEPATIC ENCEPHALOPATHY 130
THU-464 aMAP score predicts progression-free survival in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinoma 130
Chemokines and Inflammatory Mediators in Erosive Esophagitis (EE) Compared to Non-Erosive Reflux Disease (NERD) and Control Patients 129
5-YEAR ONCOLOGIC OUTCOMES FOR ROBOT-ASSISTED AND LAPAROSCOPIC PARTIAL NEPHRECTOMY FOR HIGH-RISK RENAL TUMORS 128
66 ABERRANT GENES PROMOTER METHYLATION IN NEURAL-CREST DERIVED TUMOURS 128
Assessment of renal damage following warm ischemia time during LPN: results of a prospective study 127
45 GENE EXPRESSION OF SOMATOSTATIN RECEPTOR SUBTYPES SSTR2a, SSTR3 AND SSTR5 IN PERIPHERAL BLOOD OF NEUROENDOCRINE LUNG CANCER AFFECTED PATIENTS 127
Long non-coding RNA HSAT II as a new biomarker for the identification of high risk intraductal papillary mucinous neoplasms (IPMNs). 127
Different Levels of Alkaline Phospatase (ALP) in Multiple Myeloma (MM) and SOLID Tumors with BONE Lesions 127
Fetal head-symphysis distance: a simple and reliable ultrasound parameter for the intrapartum assessment of the fetal head descent 126
Biological effects of cabozantinib on osteosarcoma-bone microenvironment model 126
The ability of Lung High-Resolution Computed Tomography Severity Score to early identify COVID-19 patients who need respiratory support. A retrospective analysis of a monocentric Italian COVID-19 cohort 125
). IL-6 e TGF-b1 nel siero e nei sovranatanti di cellule mononucleate in pazienti con sclerosi sistemica (SSC). 124
Baccalaureate nursing students’ attitudes towards old people 124
Body Mass Index and Impaired Fasting Blood Glucose as Predictive Factors of Efficacy in Cetuximab-Based Colorectal Cancer Treatment 123
How long is the latent phase of labour? 122
"NO CLAMPING-NO SUTURING" LAPAROSCOPIC PARTIAL NEPHRECTOMY (LPN). 122
Continent ileocolonic urinary diversion (rome pouch) for gynecologic malignancies: techniqueand feasibility. 122
Amniotic membrane produces and releases nerve growth factor (NGF) and expresses NGF receptors 121
LPS AND RADIATION-INDUCED GUT PERMEABILITY DAMAGE: FOCUS ON THE POTENTIAL BENEFICIAL EFFECT OF GRAPE SEED EXTRACT 120
Integrated treatment of pancreatic head carcinoma 119
T.07.3: CHARACTERISTICS AND OUTCOMES OF IMMUNOTHERAPYRELATED LIVER INJURY IN PATIENTS WITH HEPATOCELLULAR CARCINOMA COMPARED TO PATIENTS WITH ADVANCED SOLID TUMOURS 118
Aberrant cytokine expression and severity of the infiltrates are reverted by rituximab therapy in salivary glands of patients with Sjogren’s syndrome 118
ALT levels are associated with metabolic parameters and age in a large real-life population. 118
Combined multimodality treatment of primary or recurrent locally advanced rectal cancer 113
Association between clinical, histopathological and molecular features in primary Sjogren's Syndrome: a retrospective study 112
Drug releasing hybrid scaffold: new avenue in cardiovascular tissue engineering 111
Adjuvant external and intraoperative radiation therapy in resectable pancreatic cancer 110
How the different systemic organ involvements are overlapped in patients with primary Sjogren syndrome: analysis using a mathematical model 110
Totale 18.089
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022691 0 0 0 0 57 8 6 3 24 32 13 548
2022/2023387 29 11 8 32 43 26 33 22 24 35 108 16
2023/20241.848 82 163 75 113 203 818 33 84 22 135 35 85
2024/202515.416 230 198 621 65 107 342 218 69 1.260 1.172 5.231 5.903
2025/202614.752 1.366 507 1.119 1.671 536 1.026 4.469 725 998 1.110 676 549
2026/20273.708 162 1.370 858 1.229 89 0 0 0 0 0 0 0
Totale 36.819